These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4). Genung NE; Guckian KM Prog Med Chem; 2017; 56():117-163. PubMed ID: 28314411 [TBL] [Abstract][Full Text] [Related]
14. Construction of IRAK4 inhibitor activity prediction model based on machine learning. Zhao Y; Wan Q; He X Mol Divers; 2024 Jul; ():. PubMed ID: 38970641 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice. Wang H; Zhou H; Zhang Q; Poulsen KL; Taylor V; McMullen MR; Czarnecki D; Dasarathy D; Yu M; Liao Y; Allende DS; Chen X; Hong L; Zhao J; Yang J; Nagy LE; Li X J Hepatol; 2020 Dec; 73(6):1470-1481. PubMed ID: 32682051 [TBL] [Abstract][Full Text] [Related]
16. Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation. McElroy WT; Tan Z; Ho G; Paliwal S; Li G; Seganish WM; Tulshian D; Tata J; Fischmann TO; Sondey C; Bian H; Bober L; Jackson J; Garlisi CG; Devito K; Fossetta J; Lundell D; Niu X ACS Med Chem Lett; 2015 Jun; 6(6):677-82. PubMed ID: 26101573 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity. Rajapaksa NS; Gobbi A; Drobnick J; Do S; Kolesnikov A; Liang J; Chen Y; Sujatha-Bhaskar S; Huang Z; Brightbill H; Francis R; Yu C; Choo EF; DeMent K; Ran Y; An L; Emson C; Maher J; Wai J; McKenzie BS; Lupardus PJ; Zarrin AA; Kiefer JR; Bryan MC ACS Med Chem Lett; 2020 Mar; 11(3):327-333. PubMed ID: 32184965 [TBL] [Abstract][Full Text] [Related]
18. IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases. Lavazais S; Jargosch M; Dupont S; Labéguère F; Menet C; Jagerschmidt C; Ohm F; Kupcsik L; Parent I; Cottereaux C; Marsais F; Oste L; Van de Water A; Christophe T; De Vos S; Fallon P; Lauffer F; Clément-Lacroix P; Eyerich K; Brys R Sci Transl Med; 2023 Feb; 15(683):eabj3289. PubMed ID: 36791209 [TBL] [Abstract][Full Text] [Related]
19. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies. Bhujbal SP; He W; Hah JM Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844 [TBL] [Abstract][Full Text] [Related]
20. Optimization of Pyrimidine Compounds as Potent JAK1 Inhibitors and the Discovery of R507 as a Clinical Candidate. Chen Y; Li H; Yen R; Heckrodt TJ; McMurtrie D; Singh R; Taylor V; Masuda ES; Park G; Payan DG ACS Med Chem Lett; 2022 Nov; 13(11):1805-1811. PubMed ID: 36385926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]